Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

AZD1390 × Sarcoma × 90 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 3 Sarcoma 1

Conditions

Interventions

Specimen Handling 32 Magnetic Resonance Spectroscopy 27 Cyclophosphamide 26 Temozolomide 20 Doxorubicin 20 Biopsy 20 Radiotherapy 18 pembrolizumab 16 Vincristine 14 Radiation 14 Irinotecan 13 fludarabine 12 X-Rays 11 Nivolumab 11 Ifosfamide 11 Gemcitabine 11 atezolizumab 10 Surgical Procedures, Operative 10 Sunitinib 7 Phantoms, Imaging 7 Imatinib Mesylate 7 Etoposide 7 Blood Specimen Collection 7 regorafenib 6 cabozantinib 6 Paclitaxel 6 Ipilimumab 6 pazopanib 5 olaparib 5 liposomal doxorubicin 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05116254 2026-01-23

SADDRIN-1

The Netherlands Cancer Institute

Phase 1 Terminated

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡